United States · FDA National Drug Code directory
Uretron D/S
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 12539-144_463c4009-d0c3-e6a2-e063-6394a90ac76a
- Product NDC
- 12539-144
- Form
- TABLET
- Composition / generic term
- Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
- Labeler
- DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20221007
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE — 40.8 mg/1
- PHENYL SALICYLATE — 36.2 mg/1
- HYOSCYAMINE SULFATE — .12 mg/1
- METHYLENE BLUE — 10.8 mg/1
- METHENAMINE — 81.6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (12539-144-01) · 12539-144-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →